Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Short Daily Hemodialysis and Online HDF: Which One is Better? (SHD)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Thananda Trakarnvanich, Bangkok Metropolitan Administration Medical College and Vajira Hospital
ClinicalTrials.gov Identifier:
NCT00939445
First received: July 14, 2009
Last updated: December 13, 2015
Last verified: December 2015

July 14, 2009
December 13, 2015
June 2009
September 2011   (final data collection date for primary outcome measure)
Adequacy [ Time Frame: 3 months ] [ Designated as safety issue: Yes ]
Same as current
Complete list of historical versions of study NCT00939445 on ClinicalTrials.gov Archive Site
Hematocrit, calcium, phosphorus [ Time Frame: 3 months ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Short Daily Hemodialysis and Online HDF: Which One is Better?
Short Daily Hemodialysis and Online HDF: Which One is Better?

1. To compare the efficacy of

  1. Short Daily Hemodialysis
  2. Online HDF in term of adequacy of dialysis.
The investigators intend to compare the efficacy between these modalities of treatment in terms of adequacy and also other parameters such as calcium-phosphorus balance and hematocrit
Interventional
Phase 3
Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Treatment
End Stage Renal Disease
  • Procedure: Online HDF
    Online HDF
  • Procedure: Short Daily Hemodialysis
    Short Daily Hemodialysis
  • Active Comparator: Online HDF
    Online HDF
    Intervention: Procedure: Online HDF
  • Active Comparator: Short Daily Hemodialysis
    Short Daily Hemodialysis
    Intervention: Procedure: Short Daily Hemodialysis
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
10
September 2011
September 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • stable ESRD
  • KT/V > 1.2 for thrice weekly or > 1.8 for twice weekly

Exclusion Criteria:

  • Inadequate vascular access flow rate
  • Concurrent medical illnesses
  • History of non-compliance
Both
18 Years to 70 Years   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Thailand
 
NCT00939445
VJR-NEPHRO001
Yes
Not Provided
Not Provided
Thananda Trakarnvanich, Bangkok Metropolitan Administration Medical College and Vajira Hospital
Bangkok Metropolitan Administration Medical College and Vajira Hospital
Not Provided
Not Provided
Bangkok Metropolitan Administration Medical College and Vajira Hospital
December 2015

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP